cholesterol
present
plasma
membran
target
cell
shown
import
infect
sarscov
show
cholesterol
deplet
treatment
affect
infect
sarscov
extent
infect
vesicular
stomat
virusbas
pseudotyp
contain
surfac
glycoprotein
sarscov
therefor
role
cholesterol
sarscov
infect
assign
protein
unaffect
coronaviru
protein
contradictori
report
whether
angiotensinconvert
enzym
cellular
receptor
sarscov
present
detergentresist
membran
domain
found
vero
cell
copurifi
marker
protein
detergentresist
membran
support
notion
cholesterolrich
microdomain
provid
platform
facilit
effici
interact
protein
cellular
receptor
understand
involv
cholesterol
initi
step
viral
life
cycl
appli
cellbas
bind
assay
cell
express
protein
cell
contain
angiotensinconvert
enzym
altern
use
solubl
protein
interact
partner
deplet
cholesterol
cell
reduc
bind
sexpress
cell
wherea
bind
solubl
protein
affect
result
suggest
optim
infect
requir
multival
interact
viral
attach
protein
cellular
receptor
import
cholesterolrich
membran
microdomain
interact
protein
sarscoronaviru
cellular
receptor
angiotensinconvert
enzym
introduct
cellular
infect
envelop
virus
proce
via
interact
viral
surfac
protein
cell
surfac
receptor
achiev
attach
viru
particl
cell
surfac
ii
initi
fusion
event
usual
trigger
conform
chang
fusion
protein
review
marsh
heleniu
featur
process
vari
differ
group
virus
viral
membran
may
fuse
either
plasma
membran
upon
endocytot
uptak
virion
endosom
membran
mani
virus
fusion
protein
cleav
subunit
may
occur
transport
plasma
membran
viru
releas
cell
garten
klenk
anoth
variant
involv
membran
microdomain
fusion
process
chazal
gerlier
within
membran
sphingolipid
cholesterol
form
microdomain
increas
structur
order
review
simon
ikonen
cholesterol
maintain
tight
packag
sphingolipid
satur
fatti
acid
chain
protein
partit
microdomain
other
exclud
tight
packag
lipid
compon
render
protein
resist
solubil
nonion
deterg
deplet
cholesterol
membran
drugseg
abolish
deterg
resist
pretreat
cell
reveal
virus
differ
depend
cholesterol
initi
infect
sever
virus
eg
human
immunodefici
viru
murin
leukemia
viru
herp
simplex
viru
shown
sensit
reduct
cholesterol
content
plasma
membran
liao
et
al
lu
et
al
bender
et
al
virusesinfluenza
virus
canin
distemp
viruscholesterolenrich
microdomain
appear
import
viral
membran
virolog
sieczkarski
whittak
imhoff
et
al
hand
vesicular
stomat
viru
show
decreas
infect
deplet
cholesterol
either
viral
cellular
membran
popik
et
al
imhoff
et
al
coronavirus
envelop
virus
positivestrand
rna
genom
review
enjuan
et
al
three
viral
protein
incorpor
viral
membran
e
protein
latter
play
import
role
initi
infect
sever
coronavirus
murin
hepat
viru
infecti
bronchiti
viru
human
coronaviru
sarscov
shown
cholesterol
deplet
plasma
membran
target
cell
reduc
effici
infect
nomura
et
al
thorp
gallagh
choi
et
al
imhoff
et
al
li
et
al
sarscov
cholesterol
depend
shown
either
infecti
viru
viral
pseudotyp
howev
explan
result
difficult
two
report
cellular
receptor
sarscov
angiotensinconvert
enzym
present
detergentresist
membran
domain
rather
detergentsolubl
fraction
warner
et
al
obtain
result
cho
cell
transient
express
li
et
al
endogen
vero
cell
contrast
lu
et
al
recent
identifi
raft
protein
similar
far
experiment
indic
whether
cholesterol
requir
bind
viru
cell
surfac
subsequ
fusion
event
clarifi
point
rais
show
cholesterol
deplet
replenish
affect
infect
effici
sarscov
extent
pseudotyp
contain
protein
sarscov
furthermor
show
present
detergentresist
membran
vero
cell
cell
final
provid
evid
cellbas
bind
assay
cholesterol
deplet
affect
interact
protein
studi
import
cholesterol
initi
infect
sarscov
use
viral
pseudotyp
base
replicationdefici
vsv
contain
protein
sarscov
approach
allow
us
determin
whether
cholesterol
depend
sarscov
entri
report
recent
li
et
al
assign
sole
protein
whether
depend
addit
coronaviru
protein
control
virus
use
pseudotyp
contain
g
protein
vsv
unaffect
cholesterol
deplet
popik
et
al
imhoff
et
al
infecti
bronchiti
viru
ibv
avian
coronaviru
recent
shown
sensit
reduct
cholesterol
content
plasma
membran
target
cell
imhoff
et
al
investig
involv
cholesterol
possibl
role
lipid
raft
initi
step
sarscov
infect
use
deplet
cholesterol
target
cell
known
captur
cholesterol
therebi
sequest
cholesterol
plasma
membran
result
lipid
microdomain
disrupt
biolog
process
depend
block
first
determin
effect
treatment
cholesterol
content
vero
cell
cell
use
contrast
vero
cell
commonli
use
propag
sarscov
sublin
sensit
control
viru
ibv
use
fluorometr
method
base
enzymecoupl
reaction
detect
free
cholesterol
cholesteryl
ester
found
incub
increas
amount
result
decreas
cholesterol
level
vero
cell
concentr
mm
concentr
cholesterol
reduc
data
shown
exclud
treatment
toxic
effect
analyz
viabil
cell
drug
exposur
concentr
mm
cell
exhibit
viabil
rate
compar
untreat
cell
data
shown
analyz
whether
cholesterol
deplet
affect
entri
mediat
sarscov
protein
pretreat
vero
cell
min
andaft
three
wash
stepsinfect
cell
either
pseudotyp
control
virus
ibv
respect
h
pi
infect
determin
count
fluoresc
cell
case
pseudotypeinfect
cell
fluoresc
deriv
egfp
express
vsv
genom
ibvinfect
cell
visual
immunostain
shown
fig
treatment
inhibit
infect
dosedepend
fashion
concentr
mm
mm
percentag
infect
cell
reduc
respect
compar
untreat
cell
infect
vesicular
stomat
viru
vsv
vsvgpseudotyp
virus
report
viru
entri
affect
deplet
cellular
cholesterol
popik
et
al
thorp
gallagh
imhoff
et
al
confirm
result
pseudotyp
system
fig
infecti
bronchiti
viru
ibv
avian
coronaviru
demonstr
infect
depend
cellular
cholesterol
imhoff
et
al
consist
data
ibv
infect
cholesteroldeplet
cell
result
decreas
number
infect
cell
fig
concentr
mm
infect
reduc
assess
whether
effect
infect
determin
count
egfpexpress
virus
immunostain
ibv
b
untreat
vero
cell
incub
absenc
presenc
watersolubl
cholesterol
dilut
medium
follow
infect
pseudotyp
virus
infect
rate
determin
describ
bar
repres
mean
standard
deviat
independ
experi
revers
use
exogen
cholesterol
replenish
cholesteroldeplet
cellular
membran
analyz
recoveri
viru
infect
shown
fig
addit
cholesterol
revers
inhibitori
effect
infect
fact
infect
rate
even
exceed
valu
determin
cell
treat
infect
affect
cholesterol
supplement
find
cholesterol
depend
pseudotyp
infect
relat
infect
sarscov
vero
cell
treat
mm
min
follow
infect
sarscov
multipl
infect
moi
adsorpt
period
cell
overlaid
methylcellulos
incub
h
plaqu
format
occur
shown
fig
compar
untreat
control
cell
infect
cholesteroldeplet
cell
reduc
mm
treatment
result
compar
obtain
pseudotyp
viru
contain
protein
sarscov
fig
also
includ
control
exogen
cholesterol
ad
vero
cell
min
prior
infect
sarscov
condit
cholesterol
replenish
inhibitori
effect
abolish
fig
data
confirm
cholesterol
play
critic
role
sarscov
entri
demonstr
cholesterol
depend
featur
protein
independ
coronaviru
protein
analyz
amount
express
cell
surfac
treatment
found
cholesterol
deplet
affect
surfac
express
level
sarscov
receptor
data
shown
contrast
recent
report
cholesterol
deplet
result
decreas
express
level
li
et
al
possibl
reason
discrep
discuss
later
section
understand
mechan
cholesterol
deplet
inhibit
viru
entri
defin
molecular
step
inhibit
occur
establish
cellbas
bind
assay
well
bind
assay
solubl
spike
protein
fuse
human
fc
cellbas
bind
assay
gener
cell
line
deriv
babi
hamster
kidney
cell
constitut
express
sarscov
spike
glycoprotein
monitor
amount
cell
bind
vero
cell
appli
fluoresc
fatti
acid
dye
bodipi
fl
c
incorpor
plasma
membran
fluoresc
dyelabel
cell
resuspend
serumfre
cultur
medium
ad
vero
monolay
ratio
cellsvero
cell
unbound
cell
remov
wash
pb
contain
sodium
chlorid
shown
fig
panel
c
bhk
cell
express
protein
sarscov
bound
effici
vero
cell
wherea
cell
parent
bhk
cell
detect
panel
g
h
pretreat
cell
rabbit
serum
direct
sarscov
reduc
bind
level
compar
bhk
cell
ie
compar
panel
e
f
panel
g
h
address
question
whether
assay
protein
interact
anoth
cellular
protein
perform
bind
assay
three
vero
cell
line
differ
express
determin
fac
analysi
express
level
surfac
vero
cell
line
character
ratio
fig
supplement
materi
compar
vero
number
bound
cell
reduc
sublin
vero
cell
use
bind
assay
fig
supplement
materi
result
indic
bind
cell
vero
cell
mediat
protein
sarscov
quantit
evalu
bind
cell
detach
trypsin
digest
resuspend
pb
contain
bovin
serum
albumin
bsa
subject
flow
cytometri
use
assay
analyz
import
cholesterol
bind
confluent
vero
cell
treat
follow
addit
bodipi
fl
c
label
cell
treatment
vero
cell
inhibit
bind
cell
vero
cell
dosedepend
manner
fig
concentr
mm
bind
decreas
similar
reduct
infect
rate
observ
fig
sarscov
fig
concentr
detriment
effect
cholesterol
deplet
bind
capac
cell
abolish
addit
exogen
cholesterol
fig
treatment
cholesterol
even
result
increas
bind
sexpress
cell
receptorexpress
cell
cholesterol
treatment
parent
bhk
cell
affect
unspecif
bind
vero
cell
data
shown
cellbas
bind
data
suggest
cholesterol
import
optim
interact
spike
protein
receptor
assay
allow
multiligand
interact
may
facilit
cellular
receptor
arrang
membran
microdomain
determin
whether
interact
isol
protein
membranebound
also
cholesteroldepend
appli
bind
assay
solubl
protein
cholesteroldeplet
replenish
vero
cell
incub
solubl
protein
follow
quantif
bound
protein
fig
compar
cellbas
bind
assay
bind
solubl
spike
protein
construct
depend
cholesterol
similar
amount
protein
bound
whether
cell
pretreat
andor
cholesterol
compar
control
cell
avoid
critic
solubl
protein
function
properli
fold
perform
experi
show
construct
use
recogn
antibodi
direct
protein
sarscov
fig
supplement
materi
furthermor
demonstr
solubl
protein
bind
transfect
bhk
cell
express
nontransfect
cell
bind
prevent
antibodi
direct
protein
fig
supplement
materi
sarscov
entri
cholesteroldepend
cholesterol
enrich
detergentresist
membran
microdomain
one
might
expect
cellular
receptor
sarscov
present
detergentresist
membran
howev
report
locat
detergentresist
membran
warner
et
al
li
et
al
hand
lu
et
al
recent
detect
raft
fraction
vero
clarifi
discrep
also
analyz
whether
resist
solubil
triton
contrast
previou
report
warner
et
al
li
et
al
found
substanti
amount
vero
cell
float
light
fraction
gradient
detergentresist
membran
expect
indic
raft
marker
fig
contrast
nonraft
marker
complet
solubil
recov
bottom
fraction
gradient
vero
cell
subject
analysi
detect
detergentsolubl
fraction
fig
result
indic
substanti
portion
sarscov
receptor
associ
cholesterolrich
membran
microdomain
resist
detergentsolubil
result
obtain
cell
analyz
data
shown
discrep
result
previou
report
discuss
work
extend
current
knowledg
cholesterol
depend
sarscov
entri
follow
way
confluent
vero
cell
lyse
triton
three
four
day
initi
seed
cell
lysat
subject
step
gradient
ultracentrifug
fraction
ml
collect
top
bottom
subject
sdspage
analyz
immunoblot
antibodi
direct
fraction
perform
untreat
cell
cell
pretreat
b
blot
show
repres
experi
three
compar
infecti
sarscov
vsv
pseudotyp
contain
protein
sarscov
show
cholesterol
depend
properti
protein
independ
viral
protein
ii
contrast
two
previou
report
warner
et
al
li
et
al
agreement
recent
report
lu
et
al
show
two
cell
line
sensit
sarscov
present
detergentresist
membran
iii
first
time
present
experiment
evid
indic
cholesterol
requir
effici
smediat
bind
cell
import
cholesterol
plasma
membran
target
cell
shown
number
virus
liao
et
al
lu
et
al
bender
et
al
includ
coronavirus
nomura
et
al
thorp
gallagh
choi
et
al
imhoff
et
al
li
et
al
lu
et
al
result
confirm
find
sarscov
go
beyond
initi
observ
provid
addit
data
contribut
better
understand
import
cholesterol
infect
sarscov
demonstr
cholesterol
deplet
affect
infect
sarscov
also
smediat
infect
vsv
pseudotyp
fact
inhibitori
effect
observ
system
compar
vsv
impair
abil
infect
cell
reduc
content
cholesterol
thorp
gallagh
imhoff
et
al
base
find
cholesterol
depend
sarscov
attribut
protein
appear
unaffect
viral
protein
furthermor
approach
show
cholesterol
deplet
reduc
infect
singl
replic
cycl
function
protein
earli
phase
infect
bind
cell
surfac
receptor
ii
induct
fusion
viral
cellular
membran
data
obtain
cellbas
bind
assay
indic
smediat
bind
target
cell
reduc
deplet
cholesterol
cell
hand
bind
solubl
protein
affect
differ
explain
multival
interact
viral
glycoprotein
cellular
receptor
molecul
case
cellbas
bind
assay
may
facilit
concentr
receptor
membran
microdomain
contrast
solubl
protein
interact
individu
molecul
therefor
bind
effici
similar
whether
receptor
molecul
arrang
microdomain
viru
bind
cell
also
allow
multival
interact
viral
attach
protein
cellular
receptor
therefor
arrang
membran
microdomain
would
explain
cholesterol
deplet
target
cell
reduc
infect
sarscov
analysi
surfac
express
indic
cholesterol
deplet
reduc
amount
protein
surfac
vero
cell
find
argu
explan
quantit
differ
avail
cellular
receptor
account
reduc
bind
effici
report
amount
express
cell
surfac
reduc
extent
cholesterol
deplet
li
et
al
differ
data
may
due
differ
stain
protocol
analysi
antibodi
ad
prior
treatment
wherea
report
li
cowork
antibodi
ad
cholesterol
deplet
interpret
result
cholesterol
plasma
membran
affect
conform
thu
present
antigen
epitop
note
recent
report
amount
surfac
vero
cell
also
found
reduc
lu
et
al
agreement
data
straightforward
explan
effect
cholesterol
deplet
bind
protein
would
locat
drm
concentr
receptor
microdomain
increas
effici
bind
deplet
cholesterol
target
cell
might
result
dispers
molecul
cell
surfac
abolish
spatial
concentr
membran
microdomain
fact
found
substanti
amount
vero
cell
coloc
marker
detergentresist
membran
cholesterol
deplet
result
reduct
detergentresist
membran
fraction
triton
solubil
result
obtain
cell
analyz
data
shown
find
locat
drm
contradictori
previou
report
mainli
detect
detergentsensit
fraction
warner
et
al
li
et
al
agreement
lu
et
al
reason
discrep
former
two
report
may
differ
experiment
condit
one
report
nonpolar
chines
hamster
ovari
cell
analyz
warner
et
al
wherea
polar
cell
line
vero
cell
use
studi
furthermor
determin
membran
associ
endogen
wherea
other
analyz
hamster
cell
overexpress
human
protein
warner
et
al
one
report
distribut
also
analyz
vero
cell
li
et
al
howev
indic
time
point
seed
deterg
treatment
carri
experi
confluent
vero
cell
use
three
four
day
initi
seed
differenti
state
cell
may
influenc
distribut
membran
environ
found
endogen
locat
detergentresist
membran
cell
sensit
infect
sarscov
locat
provid
explan
cholesterol
depend
viru
infect
mostlik
bind
viru
receptor
similar
observ
report
bind
dendrit
cell
dc
treatment
dc
abolish
viru
bind
indic
dcspecif
hivreceptor
present
cholesterolenrich
microdomain
lipid
bilay
gummuluru
et
al
mention
import
cholesterolrich
microdomain
infect
sarscov
may
concentr
effect
cellular
receptor
protein
cluster
certain
area
membran
may
allow
multival
bind
viru
particl
cell
surfac
way
microdomain
may
increas
effici
infect
absolut
requir
entri
process
explan
agreement
find
cholesterol
deplet
reduc
suscept
infect
abolish
infect
rate
reduc
may
appear
dramat
effect
howev
infect
host
requir
mani
replic
cycl
therefor
viru
abl
produc
twofold
higher
number
infecti
particl
one
round
infect
huge
advantag
surviv
long
run
also
evid
report
cholesterol
depend
sarscov
author
determin
infect
viru
effect
treatment
multicycl
replic
sarscov
use
approach
reduct
viru
supernat
found
demonstr
import
effici
infect
mediat
detergentresist
membran
cell
line
propag
adher
monolay
cultur
presenc
heatinactiv
fetal
calf
serum
fc
penicillinstreptomycin
antibiot
cocktail
babi
hamster
kidney
german
collect
microorgan
cell
cultur
braunschweig
germani
vero
cell
collect
cell
line
veterinari
medicin
friedrichloefflerinstitut
insel
riem
germani
grown
eagl
minim
essenti
medium
emem
vero
vero
cell
grown
dulbecco
minim
essenti
medium
dmem
hanika
et
al
cell
stabl
transfect
describ
cultur
emem
supplement
antibiot
zeocin
mg
ml
hygromycin
b
mg
ml
replicationincompet
vsv
g
gene
replac
egfp
gene
gener
describ
previous
hanika
et
al
approach
also
use
gener
sarscov
spseudotyp
vsv
report
previous
ren
et
al
stock
viru
ibv
strain
beaudetteu
sarscov
strain
frankfurt
propag
vero
vero
cell
respecitv
ibv
beaudetteu
virus
store
infect
determin
tcid
titrat
vero
vero
cell
respect
gener
untreat
cyclodextrincholesteroltr
cell
cultur
glass
coverslip
wash
prior
infect
virus
ibv
strain
beaudett
dilut
medium
infecti
unit
appli
cell
allow
bind
h
remov
inoculum
medium
contain
fc
ad
cell
h
pi
infect
cell
wash
fix
paraformaldehyd
viru
infect
cell
determin
count
egfpexpress
cell
monitor
ibv
infect
fix
cell
permeabil
triton
ibv
antigen
stain
incub
rabbit
serum
rais
ibv
strain
beaudett
follow
incub
fitcconjug
secondari
antibodi
infect
sarscov
frankfurt
strain
vero
cell
cultur
cultur
plate
reach
confluenc
next
day
cell
infect
multipl
infect
moi
viru
allow
attach
cell
h
wash
away
unbound
viru
pb
cell
overlaid
dmem
contain
methylcellulos
cell
incub
h
visual
plaqu
format
cell
fix
paraformaldehyd
follow
stain
crystal
violet
cell
line
gener
express
sarscov
glycoprotein
cell
line
design
gener
viral
pseudotyp
contain
protein
sarscov
effici
pseudotyp
report
construct
lack
carboxytermin
amino
acid
nie
et
al
therefor
mutant
gener
delet
carboxytermin
amino
acid
cytoplasm
tail
protein
gener
cell
induc
mammalian
geneswitch
system
invitrogen
use
follow
primer
design
gener
truncat
version
sarscov
protein
use
synthet
codonoptim
sequenc
gene
amino
acid
sequenc
ident
strain
genbank
access
templat
bamhiecori
digest
purifi
pcr
product
insert
vector
pgenec
give
total
open
read
frame
sequenc
found
correct
cell
line
express
truncat
sarscov
protein
gener
describ
manufactur
brief
cell
cultur
day
select
medium
contain
hygromycin
b
ml
zeocin
mg
ml
cell
clone
isol
limit
dilut
analyz
mifepristoneinduc
sarscov
express
western
blot
product
pseudoparticl
describ
reclon
step
one
cell
clone
select
use
throughout
studi
cat
watersolubl
cholesterol
cat
obtain
sigmaaldrich
vero
vero
cell
treat
differ
concentr
dilut
emem
min
cholesterol
replenish
experi
cell
first
incub
three
wash
step
cholesterol
dilut
serumfre
emem
incub
cell
min
concentr
ml
cholesterol
measur
cell
wash
pb
lyse
lysi
buffer
cholesterol
level
assay
use
amplex
red
cholesterol
assay
kit
molecular
probe
follow
manufactur
protocol
cell
viabil
assay
use
reagent
roch
brief
cell
prolifer
reagent
dilut
medium
ad
cell
incub
h
absorb
measur
elisa
reader
nm
experi
control
cell
incub
medium
indic
time
period
cellbas
bind
assay
cell
grown
cm
cultur
flask
confluenc
cultur
medium
replac
fresh
medium
contain
ml
bodipi
fl
c
molecular
probe
fc
mifepriston
induc
protein
express
accutas
treatment
paa
laboratori
cell
resuspend
emem
count
adjust
cellsml
vero
cell
incub
overnight
plate
confluent
cell
monolay
follow
cholesterol
deplet
replet
vero
cell
overlaid
cell
suspens
h
dark
three
wash
step
icecold
pb
contain
sodium
chlorid
bind
cell
visual
fluoresc
microscopi
quantif
vero
cellcel
interact
cell
mixtur
detach
resuspend
pb
contain
bsa
subject
flow
cytometri
beckman
coulter
epic
xl
flow
cytomet
analyz
use
analysi
softwar
determin
specif
cellcel
interact
cell
preincub
antisar
rabbit
serum
dilut
follow
cell
overlay
onto
vero
cell
bodipi
fl
c
label
cell
use
determin
unspecif
bind
bind
assay
solubl
protein
solubl
fc
fusion
protein
transient
express
cell
concentr
cultur
supernat
use
centriconplu
ultrafilt
millipor
incub
min
ice
cholesteroldepletedreplet
vero
cell
bound
fc
fusion
protein
subsequ
detect
use
antihuman
fitcconjug
secondari
antibodi
dako
follow
flow
cytometri
drm
prepar
accord
publish
method
castelletti
et
al
modif
step
carri
vero
cell
cultur
mm
cultur
dish
maintain
day
reach
confluenc
wash
icecold
pb
cell
scrape
ml
pb
contain
wv
complet
proteas
inhibitor
cocktail
roch
pharmaceut
homogen
repeat
passag
needl
maintain
ice
h
postnuclear
supernat
prepar
min
sampl
dilut
iodixanol
final
concentr
ml
aliquot
transfer
tube
sampl
overlaid
wv
ml
wv
ml
top
iodixanol
pb
centrifug
h
beckman
rotor
ml
fraction
harvest
top
bottom
tube
follow
separ
reduc
condit
sampl
analyz
protein
content
western
blot
detect
goat
polyclon
antibodi
r
system
use
distribut
raft
marker
protein
bd
bioscienc
nonraft
marker
protein
bd
pharmingen
use
posit
neg
control
respect
